The DEA has refused to remove cannabis from its Schedule I listing.

The DEA has refused to remove cannabis from the Schedule I category.

  • The FDA claims that cannabis has no medical benefits.

  • Schedule I is the strictest drug category we have, placing marijuana along side heroin and LSD.

  • Schedule II contains known to be dangerous and highly addictive drugs, such as, methamphetamine and oxycodone.

  • The DEA claims they are willing to continue to move forward with the scientific research of cannabis.

The country desperately tries to move forward against the war on cannabis. However, the DEA refuses to remove the plant from its Schedule I listing.

The decision should not come as a surprise. After all, if cannabis is ever federally accepted many people stand to lose their jobs. The reasoning to keep cannabis in the most dangerous drug category is surprising.

Chuck Rosenberg Chief of the Drug Enforcement Administration says the decision is based on science. The Food and Drug Administration is said to have provided Rosenberg with “enormous weight” that showed cannabis did not have any medical benefits. Remind you, The FDA has approved multiple medicines that are synthetic versions of the cannabis plant.

The FDA goes on to say that cannabis is highly vulnerable to abuse. The claim states that marijuana is still the most common illicit drug abused in the United States.

This decision isn’t based on danger. This decision is based on whether marijuana, as determined by the FDA, is a safe and effective medicine, and it’s not. -Chuck Rosenberg

How can the FDA claim cannabis has no medical benefits?

With so many claiming that cannabis has helped a wide array of medical issues, how could the FDA claim there are no medical benefits? This is where the vicious circle between our federal agency begins. It allows these agencies to bounce the responsibility back and forth off of each other.

Marijuana is a member of the Schedule I drug classification. Substances in the Schedule I classification are considered to be “drugs with no currently accepted medical use and a high potential for abuse.”

So while cannabis sits alongside heroin, and LSD in Schedule I, highly-addictive drugs, such as methamphetamine and oxycodone are considered Schedule II. Meaning, while these drugs are known to be dangerous, or highly addictive, they show medical benefits. Which allows researchers to openly do studies on these more dangerous drugs.

The FDA claims that they have no data showing cannabis to have any medical benefits what-so-ever. Researching cannabis has long been a hard task to accomplish. Nobody is allowed to conduct research on cannabis without approval from the DEA, FDA, and The National Institute on Drug Abuse. This makes it easy to simply not move forward with research.

On top of that, only The National Institute on Drug Abuse is allowed to be responsible for manufacturing and distributing marijuana for research.  At this time, the University of Mississippi is the only agency allowed to handle these processes.

The three entities prolonging cannabis, also are against cannabis.

Because cannabis is a Schedule I drug, the FDA legally cannot do research into the medical benefits without the permission of DEA and NIDA. So now we have three government agencies, who all oppose cannabis and have it in their best interest to continue to oppose cannabis, having to work together to legalize cannabis. Makes a whole lot of sense, right?

Who can remove cannabis from Schedule I?

We turn to the DEA and ask them to release cannabis from its Schedule I prison. In return they can claim that they cannot since there is no proof of the medical benefits. The FDA claims to have no evidence after years of suppressing research. Then due to the Schedule I category, NIDA swoops in to say it is the most abused drug in the country.

While these three federal agencies continue to point fingers, people are being denied a valuable medicine that is helping people around the world. Thre are two ways cannabis can be removed from a Schedule I listing. Either these federal entities have to sign off on it, or congress must pass a bill that the president signs off on. Neither option seems to be happening any day soon.

Continuing the research of cannabis.

The DEA claims to be very supportive of the research of marijuana, yet in August 2015, they limited research on the plant. They go as far as to say that they have “never denied” an application for a researcher to use legally grown marijuana in medical research. Rosenberg claimed that there is research still being conducted, namely the effects of smoking marijuana on the human body.

The federal government claims they are making efforts to expand the amount of marijuana that is available for research. In order for that to happen, more institutes need to open that are allowed to manufacture marijuana for scientific research.

Cannabidiol, better known as CBD, is much more progressive, in terms of research. The federal government made it easier to research CBD in December 2015. CBD researchers have put a focus on the towards epileptic seizures in both children and adults. The primary focus has gone towards children.

In July, the Democratic National Committee endorsed the idea of taking steps necessary to get cannabis legalized. The words “future legalization” were used, meaning that does not necessarily imply their plan would lead to anything quickly.



About Meko Haze

Meko Haze is an independent journalist by day... and an independent journalist by night.